CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

被引：1
|
作者：
Tan, Xiu Xia Sherry [1 ]
Maltez, Melissa [1 ]
Mallick, Ranjeeta [2 ]
Hamelin, Linda [1 ]
McDiarmid, Sheryl [1 ]
Kennah, Michael [1 ]
Atkins, Harold [1 ]
Kekre, Natasha K. [1 ]
机构：
[1] Ottawa Hosp, Dept Med, Ottawa, ON, Canada
[2] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
    Wang, Jia
    Yuan, Ji-jun
    Mu, Juan
    Li, Qing
    Mou, Nan
    Yang, Zhen-xing
    Li, Wei
    Li, Lanfang
    Zhao, Peiqi
    Wang, Xianhuo
    Pu, Yedi
    Zhang, Huilai
    Deng, Qi
    BLOOD, 2019, 134
  • [42] Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2 nd Line CAR T Therapy
    Schneider, Michael
    Chong, Elise A.
    Barta, Stefan K.
    Nasta, Sunita D.
    Svoboda, Jakub
    Carter, Jordan
    Cook, Michael Roderick
    Hossain, Nasheed
    Schuster, Stephen J.
    Difilippo, Heather
    Plastaras, John P.
    Lariviere, Michael
    Ruella, Marco
    Porter, David L.
    Frey, Noelle
    Landsburg, Daniel J.
    BLOOD, 2024, 144 : 5123 - 5124
  • [43] Impact of Bridging Chemotherapy on Clinical Outcomes of CD19 CAR T Therapy in Relapse/Refractory Diffuse Large B- Cell Lymphoma in Real World Experience
    Paillassa, Jerome
    Vercellino, Laetitia
    Di Blasi, Roberta
    Bernard, Sophie
    Moatti, Hannah
    Bommier, Come
    Guerra, Matteo
    Meignin, Veronique
    Chevret, Sylvie
    Thieblemont, Catherine
    BLOOD, 2019, 134
  • [44] A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma
    Zhitao Ying
    Ting He
    Shanzhao Jin
    Xiaopei Wang
    Wen Zheng
    Ningjing Lin
    Meifeng Tu
    Yan Xie
    Lingyan Ping
    Weiping Liu
    Lijuan Deng
    Yanping Ding
    Xuelian Hu
    Bing Bu
    Xin'an Lu
    Yuqin Song
    Jun Zhu
    ChineseJournalofCancerResearch, 2022, 34 (01) : 53 - 67
  • [45] A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma
    Ying, Zhitao
    He, Ting
    Jin, Shanzhao
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Liu, Weiping
    Deng, Lijuan
    Ding, Yanping
    Hu, Xuelian
    Bu, Bing
    Lu, Xin'an
    Song, Yuqin
    Zhu, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2022, 34 (01)
  • [46] Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma
    Othman, Tamer
    Baird, John H.
    Pak, Stacy
    Mei, Matthew
    Herrera, Alex F.
    Mansour, Joshua
    Shouse, Geoffrey
    Sahebi, Firoozeh
    Spielberger, Ricardo
    Cai, Ji-Lian
    Farol, Leonardo
    Godfrey, James
    Kallam, Avyakta
    Phillips, Tycel
    Popplewell, Leslie
    Siddiqi, Tanya
    Forman, Stephen
    Budde, Lihua E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 368 - 372
  • [47] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2020, 136
  • [48] A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
    Bachy, Emmanuel
    Le Gouill, Steven
    Di Blasi, Roberta
    Sesques, Pierre
    Manson, Guillaume
    Cartron, Guillaume
    Beauvais, David
    Roulin, Louise
    Gros, Francois Xavier
    Rubio, Marie Therese
    Bories, Pierre
    Bay, Jacques Olivier
    Llorente, Cristina Castilla
    Choquet, Sylvain
    Casasnovas, Rene-Olivier
    Mohty, Mohamad
    Guidez, Stephanie
    Joris, Magalie
    Loschi, Michael
    Carras, Sylvain
    Abraham, Julie
    Chauchet, Adrien
    La Rochelle, Laurianne Drieu
    Deau-Fischer, Benedicte
    Hermine, Olivier
    Gastinne, Thomas
    Tudesq, Jean Jacques
    Gat, Elodie
    Broussais, Florence
    Thieblemont, Catherine
    Houot, Roch
    Morschhauser, Franck
    NATURE MEDICINE, 2022, 28 (10) : 2145 - 2154
  • [49] Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma
    Stock, Sophia
    Bucklein, Veit L.
    Blumenberg, Viktoria
    Magno, Giulia
    Emhardt, Alica-Joana
    Holzem, Alessandra M. E.
    dos Santos, David M. Cordas
    Schmidt, Christian
    Griesshammer, Stefanie
    Frolich, Lisa
    Kobold, Sebastian
    von Bergwelt-Baildon, Michael
    Rejeski, Kai
    Subklewe, Marion
    HEMASPHERE, 2025, 9 (01):
  • [50] A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
    Emmanuel Bachy
    Steven Le Gouill
    Roberta Di Blasi
    Pierre Sesques
    Guillaume Manson
    Guillaume Cartron
    David Beauvais
    Louise Roulin
    François Xavier Gros
    Marie Thérèse Rubio
    Pierre Bories
    Jacques Olivier Bay
    Cristina Castilla Llorente
    Sylvain Choquet
    René-Olivier Casasnovas
    Mohamad Mohty
    Stéphanie Guidez
    Magalie Joris
    Michaël Loschi
    Sylvain Carras
    Julie Abraham
    Adrien Chauchet
    Laurianne Drieu La Rochelle
    Bénédicte Deau-Fischer
    Olivier Hermine
    Thomas Gastinne
    Jean Jacques Tudesq
    Elodie Gat
    Florence Broussais
    Catherine Thieblemont
    Roch Houot
    Franck Morschhauser
    Nature Medicine, 2022, 28 : 2145 - 2154
12345